The Food and Drug Administration (FDA) has announced that it has received an emergency permit for Astraznka and Bharat vaccines from the Article 20 Commission of the Ministry of Health. It has been announced that the imported Astraznka vaccine will be purchased from South Korea and Russia.
It was in January of this year that the Indian Drug Control Agency issued an emergency permit for vaccines produced by Strazenka and Oxford University, as well as the Indian company Bharat Biotech, preparing for the world’s largest corona vaccination program. Now, almost a month later, the Ministry of Health has issued an emergency permit for the two Indian vaccines.
Haidar Mohammadi, director general of the Food and Drug Administration under the control of the Food and Drug Administration, told Fars about the latest situation of import of corona vaccines from abroad that Astraznka and Bharat vaccines of India received emergency use permits from the Article 20 Commission of the Ministry of Health “And the documentation of this vaccine was studied by the experts of the Food and Drug Administration, and after” Sputnik V “, they received an emergency use permit.”
According to Mohammadi Astrazenka, it is a multinational company and not just a British company. He emphasized that part of the research on this vaccine was done by Oxford, part of the production of this vaccine was done by Sweden and the other part was researched and produced by other countries such as India. Done.
Mohammadi stressed that the Astraznka vaccine is produced in 7 countries and stressed that the vaccine imported to Iran is not from the United States, Britain or France: “Britain, India, Russia and South Korea are among the countries that produce this vaccine. . According to the orders of the leadership, the purchase of Corona vaccine from the United States, Britain and France is prohibited and these vaccines should not be produced in these countries. Accordingly, the Food and Drug Administration decided that if this vaccine is imported, it will import the vaccine. “These countries are not produced.”
He said that if the company imports vaccines, its products will be purchased from South Korea and Russia. “It is not yet clear how many doses of this vaccine will be imported into the country,” Mohammadi said, adding that the vaccine would be purchased both through a Kwax contract and directly.
As mentioned, the Oxford vaccine, or Strazenka vaccine, is produced by several countries and it has been announced that it will produce 50 million vaccines a month. Bharat Biotech in India has also announced that it aims to produce 200 million vaccines a year.